BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:JY232 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of JY232\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07336823-3428@assetmemo.bio
DTSTAMP:20261121T005557Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:JY232: Phase 1 readout est. (NCT07336823)
DESCRIPTION:JY232\, phase 1\, Multiple Myeloma.\nStudy: JY232(JY232) Inject
 ion in Relapsed/Refractory Multiple Myeloma\nEstimated primary completion:
  31 December 2028. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/jy
 232#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 07336823
URL:https://assetmemo.bio/drug/jy232#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
